Cargando…

Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia

BACKGROUND: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease. METHODS: A retrospective record review of 348 MDR/RR-TB patients treated at All Afric...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayissa, Adamu, Demissie, Meaza, Biru, Mulatu, Akalu, Zenebe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062340/
https://www.ncbi.nlm.nih.gov/pubmed/35521633
http://dx.doi.org/10.1016/j.jctube.2022.100315
_version_ 1784698912372686848
author Bayissa, Adamu
Demissie, Meaza
Biru, Mulatu
Akalu, Zenebe
author_facet Bayissa, Adamu
Demissie, Meaza
Biru, Mulatu
Akalu, Zenebe
author_sort Bayissa, Adamu
collection PubMed
description BACKGROUND: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease. METHODS: A retrospective record review of 348 MDR/RR-TB patients treated at All African Leprosy Rehabilitation & Training (ALERT) Center from January 2014- December 2018. Categorical variables were compared using Chi-square/Fisher exact test as appropriate. Trend analysis was done using chi-square & linear regression. Logistic regression analysis was done to determine the factors associated with primary MDR/RR TB. Adjusted Odds Ratio (AOR) with 95% CI and p value < 5% were used to report factors associated. RESULT: Proportion of primary resistance among MDR/RR TB patients was 25.9% with 95% CI 21.3–30.3%. The proportion increased form 9.7% in 2014 to 43.4% in 2018 at a yearly increasing rate of 9.27%. Contact history to TB patient & year of diagnosis 2017 and 2018 were significantly associated with primary resistance AOR (95% CI) & p value 4.15(1.75–9.84) p = 0.001, 3.87(1.44–10.39) p = 0.007, 3.43(1.20–9.84) p = 0.022 respectively. CONCLUSION: The study revealed a high proportion of primary resistance among MDR/RR TB during the study period with a linearly increasing fashion thus a need for due attention in the efforts to control MDR TB.
format Online
Article
Text
id pubmed-9062340
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90623402022-05-04 Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia Bayissa, Adamu Demissie, Meaza Biru, Mulatu Akalu, Zenebe J Clin Tuberc Other Mycobact Dis Article BACKGROUND: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease. METHODS: A retrospective record review of 348 MDR/RR-TB patients treated at All African Leprosy Rehabilitation & Training (ALERT) Center from January 2014- December 2018. Categorical variables were compared using Chi-square/Fisher exact test as appropriate. Trend analysis was done using chi-square & linear regression. Logistic regression analysis was done to determine the factors associated with primary MDR/RR TB. Adjusted Odds Ratio (AOR) with 95% CI and p value < 5% were used to report factors associated. RESULT: Proportion of primary resistance among MDR/RR TB patients was 25.9% with 95% CI 21.3–30.3%. The proportion increased form 9.7% in 2014 to 43.4% in 2018 at a yearly increasing rate of 9.27%. Contact history to TB patient & year of diagnosis 2017 and 2018 were significantly associated with primary resistance AOR (95% CI) & p value 4.15(1.75–9.84) p = 0.001, 3.87(1.44–10.39) p = 0.007, 3.43(1.20–9.84) p = 0.022 respectively. CONCLUSION: The study revealed a high proportion of primary resistance among MDR/RR TB during the study period with a linearly increasing fashion thus a need for due attention in the efforts to control MDR TB. Elsevier 2022-04-25 /pmc/articles/PMC9062340/ /pubmed/35521633 http://dx.doi.org/10.1016/j.jctube.2022.100315 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Bayissa, Adamu
Demissie, Meaza
Biru, Mulatu
Akalu, Zenebe
Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
title Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
title_full Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
title_fullStr Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
title_full_unstemmed Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
title_short Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
title_sort proportion and trend of primary resistance among multidrug resistant tuberculosis patients in ethiopia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062340/
https://www.ncbi.nlm.nih.gov/pubmed/35521633
http://dx.doi.org/10.1016/j.jctube.2022.100315
work_keys_str_mv AT bayissaadamu proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia
AT demissiemeaza proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia
AT birumulatu proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia
AT akaluzenebe proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia